Sort By
-
![Maria Karlou](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="150" height="150"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Maria Karlou
To address the challenges of resistance to..
![Maria Karlou](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="277" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Maria Karlou
The 2011 PCF-Hellenic Fund Young Investigator Award
Maria Karlou, PhD:
University of Athens
Mentor:
Christopher Logothetis, MD
-
Rajan Kulkarni
Prostate cancer diagnosis and precision medicine decisions..
![Rajan Kulkarni](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="300" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Rajan Kulkarni
2014 Bari Milken Bernstein and Fred Bernstein-PCF Young Investigator
Rajan Kulkarni, MD, PhD:
David Geffen School of Medicine at UCLA
Mentors:
Matthew Rettig, MD, Dino Di Carlo, PhD
Proposal Title:
Utilizing Vortex Chip for Enumeration and Determination of Single-Cell Heterogeneity of Circulating Tumor Cells in Prostate Cancer
-
Haydn Kissick
T cells are immune cells with a..
![Haydn Kissick](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="150" height="200"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Haydn Kissick
2014 William B. Finneran-PCF Young Investigator
Haydn Kissick, PhD:
The Emory Vaccine Center and the Department of Urology, Emory University
Mentors:
Martin Sanda, MD, Rafi Ahmed, PhD
Proposal Title:
Vaccination against Patient Specific Coding Mutations to Treat Prostate Cancer
-
Charalambos Kaittanis
The poor solubility and bioavailability of many..
![Charalambos Kaittanis](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="200" height="200"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Charalambos Kaittanis
2014 David S. Blitzer-PCF Young Investigator
Charalambos Kaittanis, PhD:
Memorial Sloan-Kettering Cancer Center
Mentors:
Jan Grimm, MD, PhD, Steven M. Larson, MD
Proposal Title:
Overcoming Drug Resistance in Advanced Prostate Cancer with Multifunctional Nanosponges
-
Stacey Kenfield
Lifestyle, guidelines, and etools to improve prostate..
![Stacey Kenfield](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="201" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Stacey Kenfield
The 2012 Michael Milken – PCF Young Investigator Award
Stacey Kenfield, ScD:
University of California, San Francisco
Mentor:
June Chan, ScD
-
Kalpana Kannan
Investigating the biological significance of novel recurrent..
![Kalpana Kannan](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="253" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Kalpana Kannan
The 2012 Leon and Debra Black – PCF Young Investigator
Kalpana Kannan, PhD:
Baylor College of Medicine
Mentor:
Laising Yen, PhD and Michael Ittman, MD, PhD
-
Theodoros Karantanos
Certain oncogenic molecules in prostate cancer cells..
![Theodoros Karantanos](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="200" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Theodoros Karantanos
2013 David and Judy Fleischer-PCF Young Investigator
Theodoros Karantanos, MD:
MD Anderson Cancer Center
Mentors:
Timothy Thompson, PhD and Christopher Logothetis, MD
Project Title:
The role of aerobic glycolysis in the development of castrate resistant prostate cancer
-
Vishal Kothari
New therapeutic targets and prognostic biomarkers for..
![Vishal Kothari](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="216" height="274"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Vishal Kothari
2015 Gerry Lenfest–PCF Young Investigator
Vishal Kothari, PhD:
University of Michigan
Mentors:
Arul Chinnaiyan, MD, PhD; Felix Feng, MD
Proposal Title:
Investigating DNAPK as a Therapeutic Target and a Prognostic Biomarker in Castration-Resistant Prostate Cancer
-
Won Kim
The emergence of treatment-resistant prostate cancer (CRPC)..
![Won Kim](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="229" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Won Kim
2015 Dendreon Pharmaceuticals–PCF Young Investigator
Won Kim, MD:
University of California, San Francisco
Mentors:
Charles Ryan, MD; Eric Small, MD
Proposal Title:
Dissecting Variant Androgen Signaling Phenotypes to Guide Treatment Selection in Abiraterone Acetate and Enzalutamide-Resistant Prostate Cancer
-
Philip Kantoff, MD
View All Board Members here.
![Philip Kantoff, MD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="264" height="260"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Philip Kantoff, MD
Chief Executive Officer
Chief Medical Officer
Co-Founder
Convergent Therapeutics -
Philip Kantoff, MD
Philip Kantoff, MD received his undergraduate degree..
![Beatrice Knudsen, MD, PhD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="174" height="243"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
![Karen Knudsen, PhD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="214" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
![Peter Kuhn](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="175" height="175"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)